Cargando…
Clinical Role of Serum miR107 in Type 2 Diabetes and Related Risk Factors
Background: As the diagnostic and treatment options for diabetes improve, more attention nowadays is being paid to the exact identification of the etiopathological mechanism of type 2 diabetes (T2DM). Insulin resistance (IR) is a pathogenetic background for T2DM. Several studies demonstrate that miR...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027608/ https://www.ncbi.nlm.nih.gov/pubmed/35454146 http://dx.doi.org/10.3390/biom12040558 |
_version_ | 1784691409143463936 |
---|---|
author | Šimonienė, Diana Stukas, Darius Daukša, Albertas Veličkienė, Džilda |
author_facet | Šimonienė, Diana Stukas, Darius Daukša, Albertas Veličkienė, Džilda |
author_sort | Šimonienė, Diana |
collection | PubMed |
description | Background: As the diagnostic and treatment options for diabetes improve, more attention nowadays is being paid to the exact identification of the etiopathological mechanism of type 2 diabetes (T2DM). Insulin resistance (IR) is a pathogenetic background for T2DM. Several studies demonstrate that miRNAs play an important role in systemic inflammation and thus in T2DM pathogenesis. Overexpression of miR-107 may cause an imbalance of glucose homeostasis, obesity, and dyslipidemia, by regulating insulin sensitivity through the insulin signaling pathway. Methods: 53 patients with T2DM and 54 nondiabetic patients were involved in the study. This study aimed to examine whether miR-107 expression in the serum of patients with diabetes was different from the control group (non-diabetic) and whether miR-107 expression correlated with lipid levels, BMI, and other factors, and finally, with insulin resistance in general. Results: miR-107 expression was higher in the T2DM group than in the control group (1.33 versus 0.63 (p = 0.016). In general, miR-107 expression was directly and positively associated with BMI (r = 0.3, p = 0.01), age (r = 0.3, p = 0.004), and male gender (p = 0.006). Moreover, miR-107 was related to dyslipidemia: Patients with higher miR-107 levels had lower HDL levels (in the control group: r = −0.262, p = 0.022 vs. diabetic group: r = −0.315, p = 0.007). Finally, the overexpression of miR-107 was associated with higher HOMA-IR in the diabetic group (r = 0.373, p = 0.035). Conclusion: MiR-107 expression is higher among diabetic patients than that of nondiabetic control subjects. Higher miR-107 levels are also related to dyslipidemia (lower HDL levels)—in the general cohort and non-diabetic subjects. Moreover, higher miR-107 expression is related to insulin resistance in the diabetic group. In general, higher miR-107 expression levels are related to a higher BMI, older age, and the male gender. |
format | Online Article Text |
id | pubmed-9027608 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-90276082022-04-23 Clinical Role of Serum miR107 in Type 2 Diabetes and Related Risk Factors Šimonienė, Diana Stukas, Darius Daukša, Albertas Veličkienė, Džilda Biomolecules Article Background: As the diagnostic and treatment options for diabetes improve, more attention nowadays is being paid to the exact identification of the etiopathological mechanism of type 2 diabetes (T2DM). Insulin resistance (IR) is a pathogenetic background for T2DM. Several studies demonstrate that miRNAs play an important role in systemic inflammation and thus in T2DM pathogenesis. Overexpression of miR-107 may cause an imbalance of glucose homeostasis, obesity, and dyslipidemia, by regulating insulin sensitivity through the insulin signaling pathway. Methods: 53 patients with T2DM and 54 nondiabetic patients were involved in the study. This study aimed to examine whether miR-107 expression in the serum of patients with diabetes was different from the control group (non-diabetic) and whether miR-107 expression correlated with lipid levels, BMI, and other factors, and finally, with insulin resistance in general. Results: miR-107 expression was higher in the T2DM group than in the control group (1.33 versus 0.63 (p = 0.016). In general, miR-107 expression was directly and positively associated with BMI (r = 0.3, p = 0.01), age (r = 0.3, p = 0.004), and male gender (p = 0.006). Moreover, miR-107 was related to dyslipidemia: Patients with higher miR-107 levels had lower HDL levels (in the control group: r = −0.262, p = 0.022 vs. diabetic group: r = −0.315, p = 0.007). Finally, the overexpression of miR-107 was associated with higher HOMA-IR in the diabetic group (r = 0.373, p = 0.035). Conclusion: MiR-107 expression is higher among diabetic patients than that of nondiabetic control subjects. Higher miR-107 levels are also related to dyslipidemia (lower HDL levels)—in the general cohort and non-diabetic subjects. Moreover, higher miR-107 expression is related to insulin resistance in the diabetic group. In general, higher miR-107 expression levels are related to a higher BMI, older age, and the male gender. MDPI 2022-04-08 /pmc/articles/PMC9027608/ /pubmed/35454146 http://dx.doi.org/10.3390/biom12040558 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Šimonienė, Diana Stukas, Darius Daukša, Albertas Veličkienė, Džilda Clinical Role of Serum miR107 in Type 2 Diabetes and Related Risk Factors |
title | Clinical Role of Serum miR107 in Type 2 Diabetes and Related Risk Factors |
title_full | Clinical Role of Serum miR107 in Type 2 Diabetes and Related Risk Factors |
title_fullStr | Clinical Role of Serum miR107 in Type 2 Diabetes and Related Risk Factors |
title_full_unstemmed | Clinical Role of Serum miR107 in Type 2 Diabetes and Related Risk Factors |
title_short | Clinical Role of Serum miR107 in Type 2 Diabetes and Related Risk Factors |
title_sort | clinical role of serum mir107 in type 2 diabetes and related risk factors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027608/ https://www.ncbi.nlm.nih.gov/pubmed/35454146 http://dx.doi.org/10.3390/biom12040558 |
work_keys_str_mv | AT simonienediana clinicalroleofserummir107intype2diabetesandrelatedriskfactors AT stukasdarius clinicalroleofserummir107intype2diabetesandrelatedriskfactors AT dauksaalbertas clinicalroleofserummir107intype2diabetesandrelatedriskfactors AT velickienedzilda clinicalroleofserummir107intype2diabetesandrelatedriskfactors |